Related Experiment Video

Updated: Jun 26, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Effect of hepatitis G virus infection on chronic hepatitis C

E Tanaka1, H J Alter, Y Nakatsuji

  • 1Shinshu University School of Medicine, Nagana-ken, Japan.

Annals of Internal Medicine
|November 1, 1996
PubMed

Insights

Hepatitis G virus (HGV) co-infection does not alter chronic hepatitis C (HCV) clinical presentation or treatment response. Interferon-alpha therapy reduced HGV RNA, but sustained responses were rare in this study of HCV patients.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Chronic hepatitis C (HCV) is a significant global health concern.
  • Hepatitis G virus (HGV) is a flavivirus that can co-infect patients with HCV.
  • The clinical impact of HGV co-infection on HCV progression and treatment remains incompletely understood.

Purpose of the Study:

  • To investigate the influence of Hepatitis G virus (HGV) infection on the clinical course of chronic hepatitis C (HCV).
  • To compare clinical features, viral markers, and interferon-alpha treatment response in patients with and without HGV co-infection.

Main Methods:

  • Retrospective study involving 189 patients with histologically confirmed chronic hepatitis C.
  • Serum HGV RNA levels were quantified using reverse-transcription polymerase chain reaction (RT-PCR).
  • Clinical data, HCV markers, and interferon-alpha treatment outcomes were analyzed and compared between HGV RNA-positive and HGV RNA-negative groups.

Main Results:

  • HGV RNA was detected in 11% of chronic hepatitis C patients.
  • Demographic and clinical characteristics, including HCV genotype and RNA levels, were similar between HGV-positive and HGV-negative patients.
  • The sustained response rate to interferon-alpha for HCV was comparable in co-infected (30%) and non-co-infected (36%) patients.

Conclusions:

  • Hepatitis G virus co-infection does not appear to significantly affect the clinical presentation or virologic course of chronic hepatitis C.
  • HGV infection showed sensitivity to interferon-alpha therapy, but sustained virologic response was uncommon.
  • These findings suggest HGV has a limited impact on chronic HCV management and outcomes.
Abstract

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...